Cryolife Inc  

(Public, NYSE:CRY)   Watch this stock  
Find more results for ASHLEY M. CAPPS�
9.85
-0.15 (-1.50%)
Apr 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 9.83 - 10.06
52 week 5.65 - 12.14
Open 10.01
Vol / Avg. 95,700.00/152,682.00
Mkt cap 276.51M
P/E 17.42
Div/yield 0.03/1.12
EPS 0.57
Shares 28.07M
Beta 1.04
Inst. own 61%
Jul 21, 2014
Q2 2014 CryoLife, Inc. Earnings Release (Estimated) Add to calendar
May 21, 2014
CryoLife, Inc. Annual Shareholder Meeting - 10:00AM EDT - Add to calendar
Apr 29, 2014
Q1 2014 CryoLife, Inc. Earnings Conference Call - 10:00AM EDT - Add to calendar
Apr 29, 2014
Q1 2014 CryoLife, Inc. Earnings Release - 9:30AM EDT - Add to calendar
Feb 20, 2014
Q4 2013 CryoLife, Inc. Earnings Conference Call - Webcast
Feb 20, 2014
Q4 2013 CryoLife, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 25.46% 11.49%
Operating margin -0.27% 7.52%
EBITD margin - 13.97%
Return on average assets 21.43% 9.75%
Return on average equity 25.34% 11.58%
Employees 488 -
CDP Score - -

Address

STE 142, 1655 ROBERTS BOULEVARD N W
KENNESAW, GA 30144
United States - Map
+1-770-4193355 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CryoLife, Inc. (CryoLife,) is a biological medical device company. The Company preserves and distributes human tissues for transplantation and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve (CryoValve SGPV) and the CryoPatch SG pulmonary cardiac patch tissue (CryoPatch SG), both processed using CryoLife�s SynerGraft technology. The Company operates in two segments: preservation services and medical devices segment. In May 2011, it acquired Cardiogenesis Corporation. In February 2014, CryoLife Inc announced the establishment of CryoLife Asia Pacific Pte. Ltd.

Officers and directors

Steven G. Anderson Chairman of the Board, President, Chief Executive Officer
Age: 74
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
D. Ashley Lee CPA Chief Financial Officer, Chief Operating Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
David P. Lang Senior Vice President - International Sales and Marketing
Age: 66
Bio & Compensation  - Reuters
Jeffrey W. Burris Esq. Vice President, General Counsel
Age: 41
Bio & Compensation  - Reuters
Bruce G. Anderson Vice President - U.S. Sales and Marketing
Age: 46
Bio & Compensation  - Reuters
Scott B. Capps Vice President - Clinical Research
Age: 46
Bio & Compensation  - Reuters
David M. Fronk Vice President - Regulatory Affairs and Quality Assurance
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David C. Gale Ph.D. Vice President - Research & Development
Age: 45
Bio & Compensation  - Reuters
Jon W. Salveson Director
Age: 48
Bio & Compensation  - Reuters
Thomas F. Ackerman Independent Director
Age: 58
Bio & Compensation  - Reuters